Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenneth E. Hung
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
New Insights Into the Molecular Pathogenesis of Colorectal Cancer
Drug Discovery Today: Disease Mechanisms
Related publications
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Cancer Cell
Cancer Research
Oncology
Cell Biology
Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells
Cancer Discovery
Oncology
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
MEK Nuclear Localization Promotes YAP Stability via Sequestering Β-TrCP in KRAS Mutant Cancer Cells
Cell Death and Differentiation
Cell Biology
Molecular Biology
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
Inhibition of EGFR, HER2, and HER3 Signalling in Patients With Colorectal Cancer Wild-Type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): A Phase 2–3 Randomised Trial
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Autophagy Inhibition Promotes Bevacizumab-Induced Apoptosis and Proliferation Inhibition in Colorectal Cancer Cells
Journal of Cancer
Oncology